VitaNova Life Sciences (YJGJ) Enterprise Value (2017 - 2026)
VitaNova Life Sciences (YJGJ) has disclosed Enterprise Value for 8 consecutive years, with -$1.3 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 465.22% year-over-year to -$1.3 million, compared with a TTM value of -$1.3 million through Oct 2025, down 465.22%, and an annual FY2025 reading of -$782810.0, down 32.0% over the prior year.
- Enterprise Value was -$1.3 million for Q4 2025 at VitaNova Life Sciences, down from -$1.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$8728.0 in Q2 2023 and bottomed at -$1.3 million in Q4 2025.
- Average Enterprise Value over 5 years is -$362483.5, with a median of -$141635.0 recorded in 2024.
- The sharpest move saw Enterprise Value skyrocketed 70.18% in 2023, then crashed 7240.02% in 2024.
- Year by year, Enterprise Value stood at -$31693.0 in 2021, then decreased by 14.19% to -$36190.0 in 2022, then soared by 75.88% to -$8728.0 in 2023, then crashed by 2452.65% to -$222795.0 in 2024, then crashed by 465.22% to -$1.3 million in 2025.
- Business Quant data shows Enterprise Value for YJGJ at -$1.3 million in Q4 2025, -$1.0 million in Q3 2025, and -$782810.0 in Q2 2025.